FDA warns about rare but serious risks o...

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab) 

Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma ... Show More

Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast Media 

Osteoporosis in dialysis patients is a challenging yet crucial aspect of kidney care, often overshadowed by more familiar concerns. This episode of Life as a Nephrology Professional brings together experts to uncover the unique dynamics of bone disease in end-stage kidney disease ... Show More

<p>Question-based Review on Differential Diagnosis of Hypercalcemia (Pseudohypercalcemia, PTH-dependent vs PTH-independent Hypercalcemia) and Hypocalcemia; Vitamin D abnormalities, Abnormalities of Phosphate. Also discussed: Workup &amp; Management of Humoral Hypercalcemia of Mal ... Show More

Who’s really at risk for fractures, and how should we be treating them? Most fragility fractures occur in patients without osteoporosis. Should we rethink who gets treated? And could just one or two IV infusions (spread years apart) of zoledronate prevent fractures for years? Hav ... Show More

Clarification of new evidence that Bisphosphonates for osteoporosis may actually weaken bones if people are left on them for too long ; Dietary change using FODMAPS to treat Irritable bowel syndrome when medicines have not worked; CRP testing for chest infections to identify whic ... Show More

What does this patient's decreased creatnine clearance and oliguria tell you? What risk factors are behind his condition? Would you give him contrast dye? 

Anabolic drugs activate osteoblasts and are an alternative to bisphosphonates for treating osteoporosis. Kristine Ensrud, MD, MPH, professor of medicine and epidemiology at the University of Minnesota and Minneapolis VA Healthcare System, joins JAMA Associate Editor Carolyn Crand ... Show More

Join KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Chuck Herzog as they explore the challenges that occur when managing dyskalemia. They address the consequences of hyperkalemia and hypokalemia. They also discuss how both hospitalized ... Show More

<p>Too often we don’t consider the health of our bones until a problem occurs. To get ahead of that, two nutritionists discuss what it takes to build and support strong bones and how to avoid (and support) osteoporosis.</p> 

There are serious potential side effects to GLP-1 weight-loss drugs. This episode features audio from Is Ozempic (Semaglutide) Safe? Does It Increase Cancer Risk? Visit the video page for all sources and doctor’s notes related to this podcast. 

We take a Pre-operative study from the Annals of Surgery and talk about perioperative risk management for patients with low serum creatinine.